|
1
|
Lopes P, Nunes T, Campos D, Furlong LI,
Bauer-Mehren A, Sanz F, Carrascosa MC, Mestres J, Kors J, Singh B,
et al: Gathering and exploring scientific knowledge in
pharmacovigilance. PLoS One. 8:e830162013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Silverman SL: From randomized controlled
trials to observational studies. Am J Med. 122:114–120. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Alves C, Macedo AF and Marques FB: Sources
of information used by regulatory agencies on the generation of
drug safety alerts. Eur J Clin Pharmacol. 69:2083–2094. 2013.
View Article : Google Scholar
|
|
4
|
Pal SN, Duncombe C, Falzon D and Olsson S:
WHO strategy for collecting safety data in public health
programmes: Complementing spontaneous reporting systems. Drug Saf.
36:75–81. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Naranjo CA, Busto U, Sellers EM, Sandor P,
Ruiz I, Roberts EA, Janecek E, Domecq C and Greenblatt DJ: A method
for estimating the probability of adverse drug reactions. Clin
Pharmacol Ther. 30:239–245. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kubo K, Azuma A, Kanazawa M, Kameda H,
Kusumoto M, Genma A, Saijo Y, Sakai F, Sugiyama Y, Tatsumi K, et
al: Consensus statement for the diagnosis and treatment of
drug-induced lung injuries. Respir Investig. 51:260–277. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Agbabiaka TB, Savović J and Ernst E:
Methods for causality assessment of adverse drug reactions: A
systematic review. Drug Saf. 31:21–37. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Khan LM, Al-Harthi SE, Osman AM, Sattar MA
and Ali AS: Dilemmas of the causality assessment tools in the
diagnosis of adverse drug reactions. Saudi Pharm J. 24:485–493.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kalghatgi S, Spina CS, Costello JC, Liesa
M, Morones-Ramirez JR, Slomovic S, Molina A, Shirihai OS and
Collins JJ: Bactericidal antibiotics induce mitochondrial
dysfunction and oxidative damage in Mammalian cells. Sci Transl
Med. 5:192ra852013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang X, Zhao X, Malik M and Drlica K:
Contribution of reactive oxygen species to pathways of
quinolone-mediated bacterial cell death. J Antimicrob Chemother.
65:520–524. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Costumbrado J and Ghassemzadeh S:
Spontaneous pneumothorax. StatPearls. StatPearls Publishing;
Treasure Island, FL: 2022
|
|
12
|
Ciriaco P, Rossetti F, Carretta A,
Sant'Angelo M, Arrigoni G and Negri G: Spontaneous pneumothorax in
cocaine users. QJM. 112:519–522. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bennett AC, Bennett CL, Witherspoon BJ and
Knopf KB: An evaluation of reports of ciprofloxacin, levofloxacin,
and moxifloxacin-association neuropsychiatric toxicities, long-term
disability, and aortic aneurysms/dissections disseminated by the
food and drug administration and the European medicines agency.
Expert Opin Drug Saf. 18:1055–1063. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Reviglio VE, Hakim MA, Song JK and O'Brien
TP: Effect of topical fluoroquinolones on the expression of matrix
metalloproteinases in the cornea. BMC Ophthalmol. 3:102003.
View Article : Google Scholar
|
|
15
|
Guzzardi DG, Teng G, Kang S, Geeraert PJ,
Pattar SS, Svystonyuk DA, Belke DD and Fedak PWM: Induction of
human aortic myofibroblast-mediated extracellular matrix
dysregulation: A potential mechanism of fluoroquinolone-associated
aortopathy. J Thorac Cardiovasc Surg. 157:109–119.e2. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tsai WC, Hsu CC, Chen CP, Chang HN, Wong
AM, Lin MS and Pang JH: Ciprofloxacin up-regulates tendon cells to
express matrix metalloproteinase-2 with degradation of type I
collagen. J Orthop Res. 29:67–73. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Berillis P: The role of collagen in the
aorta structure. Open Circ Vasc J. 6:1–8. 2013. View Article : Google Scholar
|
|
18
|
Gelse K, Pöschl E and Aigner T:
Collagens-structure, function, and biosynthesis. Adv Drug Deliv
Rev. 55:1531–1546. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fujimori K, Shimatsu Y, Suzuki E, Arakawa
M and Gejyo F: Levofloxacin-induced eosinophilic pneumonia
complicated by bronchial asthma. Nihon Kokyuki Gakkai Zasshi.
38:385–390. 2000.(In Japanese).
|
|
20
|
Tohyama M, Arakaki N, Tamaki K and Shimoji
T: A case of drug-induced pneumonitis due to levofloxacin and kampo
medicine. Nihon Kokyuki Gakkai Zasshi. 44:951–956. 2006.(In
Japanese).
|
|
21
|
Shibusa T and Onuma K: A case of possible
drug-induced lung injury caused by levofloxacin. Nihon Kyoubu
Rinsho. 74:691–696. 2015.(In Japanese).
|
|
22
|
Facciolongo N, Menzella F, Castagnetti C,
Cavazza A, Piro R, Carbonelli C and Zucchi L: Eosinophilic
infiltrate in a patient with severe Legionella pneumonia as
a levofloxacin-related complication: A case report. J Med Case Rep.
4:3602010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hosogaya N, Toida K, Ishihara H and
Kugiyama K: A case of drug induced lung injury caused by
levofloxacin eye drops. Respir Med Case Rep. 24:12–15.
2018.PubMed/NCBI
|
|
24
|
Steiger D, Bubendorf L, Oberholzer M, Tamm
M and Leuppi JD: Ciprofloxacin-induced acute interstitial
pneumonitis. Eur Respir J. 23:172–174. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kimura N, Miyazaki E, Matsuno O, Abe Y and
Tsuda T: Drug-induced pneumonitis with eosinophilic infiltration
due to tosufloxacin tosilate. Nihon Kokyuki Gakkai Zasshi.
36:618–622. 1998.(In Japanese).
|
|
26
|
USA Food and Drug Administration,
Department of Health and Human Services, . NDA approval No.
050684/S-055S-061050750/S-016, S-020. Available from. https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/050684s061,050750s016ltr.pdf
|
|
27
|
Graf-Deuel E and Knoblauch A: Simultaneous
bilateral spontaneous pneumothorax. Chest. 105:1142–1146. 1994.
View Article : Google Scholar
|
|
28
|
Upadya A, Amoateng-Adjepong Y and Haddad
RG: Recurrent bilateral spontaneous pneumothorax complicating
chemotherapy for metastatic sarcoma. South Med J. 96:821–823. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee CH, Park KU, Nah DY and Won KS:
Bilateral spontaneous pneumothorax during cytotoxic chemotherapy
for angiosarcoma of the scalp: A case report. J Korean Med Sci.
18:277–280. 2003. View Article : Google Scholar
|
|
30
|
Matsuura Y, Ninomiya H, Ichinose J, Nakao
M, Ishikawa Y, Okumura S and Mun M: Pathogenesis of secondary
spontaneous pneumothorax complicating osteosarcoma. Ann Thorac
Surg. 110:e81–e83. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Boone PM, Scott RM, Marciniak SJ, Henske
EP and Raby BA: The genetics of pneumothorax. Am J Respir Crit Care
Med. 199:1344–1357. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cheng YL, Huang TW, Lin CK, Lee SC, Tzao
C, Chen JC and Chang H: The impact of smoking in primary
spontaneous pneumothorax. J Thorac Cardiovasc Surg. 138:192–195.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim D, Eom SY, Shin CS, Kim YD, Kim SW and
Hong JM: The clinical effect of smoking and environmental factors
in spontaneous pneumothorax: A case-crossover study in an Inland
province. Ther Adv Respir Dis. 14:17534666209774082020. View Article : Google Scholar : PubMed/NCBI
|
